• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORP. HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORP. HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE Back to Search Results
Model Number 104911
Device Problem Detachment Of Device Component (1104)
Patient Problem Thrombus (2101)
Event Date 10/06/2014
Event Type  Injury  
Event Description
The patient was implanted with a left ventricular assist device.The hospital reported the patient's pump had been shut-off since january and he was supported outpatient on inotropic therapy awaiting heart transplantation.On (b)(6) 2014, the decision was made to exchange his pump.The hospital reported visualization of a disconnected bend relief upon chest exploration/device removal.
 
Manufacturer Narrative
The reported pump thrombosis and subsequent pump being shut off was reported under mfr #2916596-2014-00206.The lvad was returned to the manufacturer for evaluation and is currently being analyzed.No further information is available at this time.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Manufacturer Narrative
The report of suspected thrombus was confirmed based on the evaluation of (b)(4); however, the report of a disconnected bend relief and a specific cause for the reported infection could not be conclusively determined.It was reported that upon device removal, the vad coordinator visualized a disconnected bend relief.The sealed outflow graft and bend relief were replaced during the exchange.However, the sealed outflow graft and bend relief were not returned for evaluation, and the reported disconnect could not be confirmed.Examination of the sealed inflow conduit revealed a strongly adhered deposition situated in the lumen of the inlet tube.The deposition appeared to be consistent with collapsed lining that developed in this area.The deposition appeared to have developed due to poor surface washing, caused by a low flow event or an interruption in flow through the pump.It was reported that the pump was turned off for an extended period of time, which likely contributed to the formation of the deposition.Examination of the rotor revealed a non-laminated deposition situated in between the blades of the rotor.The structure of the deposition suggested that it did not develop on the rotor.Although its origins cannot be conclusively determined, the deposition had areas that appeared denatured which is indication that the deposition was likely present while the pump was in operation.Examination of the pump bearings, rotor, and blood-contacting surfaces under a microscope, revealed no abnormalities that would have contributed to the formation of the thrombus.The pump was cleaned, reassembled, and functionally tested under loaded conditions using a mock circulatory loop.The retrieved data revealed normal pump power consumption comparable to the pump power consumption recorded during the manufacturing process, and the pump operated as intended.A review of the device history record revealed that the device met applicable specifications.No further information is available.The manufacturer is closing the file on this event.
 
Manufacturer Narrative
No further information is available at this time.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
The patient expired on (b)(6) 2014 due to multisystem organ failure.According to the vad coordinator, the patient had an ongoing pump pocket infection and bacteremia prior to the patient's pump exchange on (b)(6) 2014.The infection was unable to be resolved through antibiotics.The center and the patient's family decided to withdraw support and the patient expired.There were no reported device issues on the patient's current pump.
 
Manufacturer Narrative
The user facility medwatch report was received from the (b)(4) registry.The user facility number was not provided.(b)(4).
 
Event Description
Additional information was received from the (b)(4) registry stating: air noted in lvad on ct of (b)(6) 2014.Decision made to replace pump.Additional information also included indicated that the patient expired on (b)(6) 2014 due to multisystem organ failure.Device function normal: yes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE
Type of Device
LEFT VENTRICULAR ASSIST DEVICE
Manufacturer (Section D)
THORATEC CORP.
pleasanton CA
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
robert fryc
23 fourth avenue
burlington, MA 01803
7812720139
MDR Report Key4239452
MDR Text Key5012261
Report Number2916596-2014-01867
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 10/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/30/2013
Device Model Number104911
Device Catalogue Number104911
Device Lot Number110282
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer10/13/2014
Is the Reporter a Health Professional? No
Device Age33 MO
Date Manufacturer Received04/30/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/20/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age49 YR
Patient Weight82
-
-